Procter & Gamble (PG) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Procter & Gamble (PG)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

145.10

-1.44 (0.98%)

as of Jun 8, 2026, 8:00:00 pm Market Open.

239 watching

Investor Insights

Jun 8, 2026, 12:00 am

This summary was created by AI, based on 12 opinions in the last 12 months.

Procter & Gamble (PG) has faced significant challenges in the consumer staples sector recently, with reports indicating a drop of 14.4% over the past year. Despite this downturn, PG is recognized for its strong brand portfolio and stable dividend yield of approximately 3%, which appeals to investors seeking safer options amidst economic uncertainties. The company is currently under pressure from rising input costs and a fluctuating economy, which could limit future earnings growth. While some experts express caution, suggesting a defensive stance and gradual investment due to potential further declines, others see the stock as undervalued at a price-to-earnings ratio of around 20x. The overall sentiment highlights a mix of optimism for PG's long-term stability and concern over the near-term performance amid challenging consumer conditions.

Consensus

Cautious

Valuation

Undervalued

Similar

Nestle, NESN

BUY

A classic defensive stock but has also been a great growth stock. Some changes in management really spurred innovations. The Gillette acquisition seems to be working out well.

BUY

On his radar. Money has been flowing into the stock in the last couple of months and he thinks that will continue. They acquired Gillette which is a big integration.

BUY

The purchase of Gillette made a big difference in terms of products they have. 2.2% yield. There has been some margin squeeze but they do have pricing power. Able to pass cost increases on.

HOLD

Basically has gone sideways but pulled back a little bit after its merger with Gillette. When you look at a global consumers product company, it is well positioned. If you believe in global growth and you want purchasing power, it is a very strong business. Not overly expensive.

DON'T BUY

Has been growing every year and has merged with Gillette. Recently got hit when Wal-Mart reduced inventories by 15% which could affect their sales short term. Trades around 18 X next year’s earnings. If the US$ falls, sales outside the US will look better. Doesn’t like exposure to the US$.

HOLD

A worthwhile holding. It's the kind of stock that does well when the general market is kind of soggy. Hasn't been a lot of enthusiasm for this kind of lower growth, defensive name.

DON'T BUY

The balance sheet is too big. His model price is $47 which is a -17.5% differential. Dead money.

BUY

This is a great company. The Gillette acquisition is a great one. The company has a good record of making acquisitions work. They generate a lot of cash flow.

BUY

A good defensive name. The acquisition of Gillette will allow sales people to now distribute both products. Likes it long term.

TOP PICK

Likes that they have leading brand names and diverisified geographically. The Gillette acquisition will be very positive. Not expensive relative to its 11/12% organic growth rate.

BUY

In a sector that is relativel safe. Everytime there has a been a correction on this stock, it tends to move sideways, so basically it is in fairly good support. Be prepared to sell if it takes out its lows of '05.

WEAK BUY

Looking to acquire Gillette (G-N) and thinks this is a good accretive deal. It gives them 15 brands with over $1 billion US of sales. Relatively expensive. May not grow quite as fast going forward because of margin squeeze.

BUY

Usually doesn't invest in large companies. Has had rising earnings every year for a long time. Dividends have been going up every year. Very stable business. Trades at about 21 X earnings. A good Buy and Hold company.

DON'T BUY

Trades at 20/21 X earnings with a yield of about 2%. Has been pretty choppy over the last year. Gillette acquisition is pretty representative of the big pharmas style in the last few years of generating some top line growth. Expect it to just grind sideways. Not ridiculously expensive based on its pristine balance sheet, but not very exciting.

DON'T BUY

They have to start getting through the integration of Gillette and have to start to see the benefits come out of that. This was one of the very large caps that became overowned in the 90's and the ownership has been washing its way out of the system. The growth rate really hasn't been there to support the multiple that it originally had.

Showing 196 to 210 of 234 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Procter & Gamble (PG)